Tumour rejection antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8519109
APP PUB NO 20090209034A1
SERIAL NO

12364746

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD666 THIRD AVENUE 28TH FLOOR NEW YORK NY 10017

International Classification(s)

loading....
  • 2009 Application Filing Year
  • C07H Class
  • 2347 Applications Filed
  • 1010 Patents Issued To-Date
  • 43.04 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances20092010201120122013201420152016201720182019202020210255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boon-Falleur, Thierry Brussels, BE 156 1105
Brasseur, Francis Brussels, BE 16 63
De, Plaen Etienne Brussels, BE 26 551
Huang, Lan-Qing Baltimore, US 2 3
van, Pel Aline Brussels, BE 19 306

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 27, 2025